Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 370


Alginate inhibits iron absorption from ferrous gluconate in a randomized controlled trial and reduces iron uptake into Caco-2 cells.

Wawer AA, Harvey LJ, Dainty JR, Perez-Moral N, Sharp P, Fairweather-Tait SJ.

PLoS One. 2014 Nov 12;9(11):e112144. doi: 10.1371/journal.pone.0112144.


Impact of vitamin D supplementation during lactation on vitamin D status and body composition of mother-infant pairs: a MAVID randomized controlled trial.

Czech-Kowalska J, Latka-Grot J, Bulsiewicz D, Jaworski M, Pludowski P, Wygledowska G, Chazan B, Pawlus B, Zochowska A, Borszewska-Kornacka MK, Karczmarewicz E, Czekuc-Kryskiewicz E, Dobrzanska A.

PLoS One. 2014 Sep 18;9(9):e107708. doi: 10.1371/journal.pone.0107708.


The role of glass ionomer cement on the remineralization of infected dentin: an in vivo study.

Kuhn E, Chibinski AC, Reis A, Wambier DS.

Pediatr Dent. 2014 Jul-Aug;36(4):E118-24.


Inhibition of xanthine oxidase and exercise on serum uric acid, 25(OH)D3, and calcium concentrations.

Sanchis-Gomar F, Salvagno GL, Lippi G.

Clin Lab. 2014;60(8):1409-11.


Reducing iron deficiency anemia in Bolivian school children: calcium and iron combined versus iron supplementation alone.

Miranda M, Olivares M, Brito A, Pizarro F.

Nutrition. 2014 Jul-Aug;30(7-8):771-5. doi: 10.1016/j.nut.2013.12.008.


Effect of niacin on FGF23 concentration in chronic kidney disease.

Rao M, Steffes M, Bostom A, Ix JH.

Am J Nephrol. 2014;39(6):484-90. doi: 10.1159/000362424.


Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal women.

Zella JB, Plum LA, Plowchalk DR, Potochoiba M, Clagett-Dame M, DeLuca HF.

Am J Nephrol. 2014;39(6):476-83. doi: 10.1159/000362846.


Effects of six months of vitamin D supplementation in patients with heart failure: a randomized double-blind controlled trial.

Dalbeni A, Scaturro G, Degan M, Minuz P, Delva P.

Nutr Metab Cardiovasc Dis. 2014 Aug;24(8):861-8. doi: 10.1016/j.numecd.2014.02.015.


Evaluation of vitamin D supplementation doses during pregnancy in a population at high risk for deficiency.

Yesiltepe Mutlu G, Ozsu E, Kalaca S, Yuksel A, Pehlevan Y, Cizmecioglu F, Hatun S.

Horm Res Paediatr. 2014;81(6):402-8. doi: 10.1159/000358833.


Plaque fluoride concentrations associated to the use of conventional and low-fluoride dentifrices.

Pessan JP, Manarelli MM, Kondo KY, de Italiani FM, Kobayashi CA, Whitford GM, Buzalaf MA.

Am J Dent. 2013 Dec;26(6):347-50.


Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b).

Greenberg B, Yaroshinsky A, Zsebo KM, Butler J, Felker GM, Voors AA, Rudy JJ, Wagner K, Hajjar RJ.

JACC Heart Fail. 2014 Feb;2(1):84-92. doi: 10.1016/j.jchf.2013.09.008.


Critical review of high-sensitivity C-reactive protein and coronary artery calcium for the guidance of statin allocation: head-to-head comparison of the JUPITER and St. Francis Heart Trials.

Kim J, McEvoy JW, Nasir K, Budoff MJ, Arad Y, Blumenthal RS, Blaha MJ.

Circ Cardiovasc Qual Outcomes. 2014 Mar;7(2):315-22. doi: 10.1161/CIRCOUTCOMES.113.000519. No abstract available.


Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia.

Carpenter TO, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Wooddell MM, Kawakami T, Ito T, Zhang X, Humphrey J, Insogna KL, Peacock M.

J Clin Invest. 2014 Apr;124(4):1587-97. doi: 10.1172/JCI72829.


Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial.

Locatelli F, Altieri P, Andrulli S, Sau G, Bolasco P, Pedrini LA, Basile C, David S, Gazzanelli L, Tampieri G, Isola E, Marzolla O, Memoli B, Ganadu M, Reina E, Bertoli S, Ferrara R, Casu D, Logias F, Tarchini R, Mattana G, Passaghe M, Fundoni G, Villa G, Di Iorio BR, Pontoriero G, Zoccali C.

Nephrol Dial Transplant. 2014 Jun;29(6):1239-46. doi: 10.1093/ndt/gfu031.


Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values.

Touvier M, Deschasaux M, Montourcy M, Sutton A, Charnaux N, Kesse-Guyot E, Fezeu LK, Latino-Martel P, Druesne-Pecollo N, Malvy D, Galan P, Hercberg S, Ezzedine K, Souberbielle JC.

J Clin Endocrinol Metab. 2014 Apr;99(4):1196-203. doi: 10.1210/jc.2013-3349.


Effect of zoledronic acid on bone mineral density in patients of celiac disease: a prospective, randomized, pilot study.

Kumar M, Rastogi A, Bhadada SK, Bhansali A, Vaiphei K, Kochhar R.

Indian J Med Res. 2013 Dec;138(6):882-7.


The impact of educational interventions on modifiable risk factors for osteoporosis after a fragility fracture.

Beaudoin C, Bessette L, Jean S, Ste-Marie LG, Brown JP.

Osteoporos Int. 2014 Jul;25(7):1821-30. doi: 10.1007/s00198-014-2618-4.


Paricalcitol- or cinacalcet-centred therapy affects markers of bone mineral disease in patients with secondary hyperparathyroidism receiving haemodialysis: results of the IMPACT-SHPT study.

Cozzolino M, Ketteler M, Martin KJ, Sharma A, Goldsmith D, Khan S.

Nephrol Dial Transplant. 2014 Apr;29(4):899-905. doi: 10.1093/ndt/gfu011.


Treatment of low bone density in young people with cystic fibrosis: a multicentre, prospective, open-label observational study of calcium and calcifediol followed by a randomised placebo-controlled trial of alendronate.

Bianchi ML, Colombo C, Assael BM, Dubini A, Lombardo M, Quattrucci S, Bella S, Collura M, Messore B, Raia V, Poli F, Bini R, Albanese CV, De Rose V, Costantini D, Romano G, Pustorino E, Magazz├╣ G, Bertasi S, Lucidi V, Traverso G, Coruzzo A, Grzejdziak AD.

Lancet Respir Med. 2013 Jul;1(5):377-85. doi: 10.1016/S2213-2600(13)70064-X.

Items per page

Supplemental Content

Loading ...
Support Center